Chao Ju Ophthalmology

Name

Chao Ju Ophthalmology

Legal name

朝聚眼科医疗控股有限公司 (Chaoju Eye Medical Holdings Limited)

Website

https://chaojueye.com

Company type

Public

Founded year

1988

Operating status

Operating

Headcount range

1,001–5,000 employees

Ownership category

akta.pro rank

Product category

Ophthalmology Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Offices of Optometrists (62132), Optical Goods Retailers (45613)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Hospitals (8060), Ophthalmic Goods (3851)

akta.pro primary industry

Ophthalmology Clinics (Medical & Surgical Eye Care) (HLAKAKAC)

akta.pro secondary industries

Ophthalmology Surgery Centers (HLAFAIAF), Optometry Clinics (Primary Eye Care) (HLAKAKAB), Comprehensive Eye Exams & Vision Care (HLAKAKAA), Cornea, External Disease & Refractive Surgery (LASIK/PRK) (HLAKAKAF), Ophthalmic Specialty Hospitals (HLAFAHAJ), Ocular Imaging & Diagnostic Testing Centers (HLAKAKAN)

Keywords

• Ophthalmology services
• Cataract surgery
• Refractive surgery
• Myopia control
• Optometry services

Headquarters

HQ city

Baotou

HQ country

China

HQ region

Asia

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Basic Eye Care Services: Cataract, glaucoma, strabismus, fundus disease, ocular surface disease, orbital disease and pediatric eye disease treatments where costs are partially covered by public medical insurance.
2. Consumer Eye Care Services: Refractive correction (including presbyopia correction), myopia prevention and control, dry eye treatment, ocular plastic surgery, and optical products and services, typically not covered by public insurance.
3. Optometry Center Products & Services: Glasses, contact lenses, orthokeratology lenses and related vision care products and services at 29 optometry centers.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Chao Ju Ophthalmology operates a national network of 31 ophthalmic hospitals and 29 optometry centers delivering comprehensive eye care across 8 specialty groups including cataract surgery, refractive surgery (SMILE, LASIK, ICL), presbyopia correction, glaucoma, fundus disease, ocular surface/dry eye, myopia control, and ophthalmic plastic surgery. Services span both insurance-covered basic eye care and self-pay consumer eye care, supported by mobile eye surgery vehicles for remote and cross-border (Mongolia) cataract missions. Revenue is generated through direct patient fees for medical procedures and retail sales of optical products.

Product overview

Chao Ju Ophthalmology operates as a leading eye care services provider with a dual-segment model comprising Consumer Ophthalmology Services (消费眼科, self-pay procedures including refractive surgery, presbyopia treatment, dry eye, cosmetic surgery, and optometry products) and Basic Ophthalmology Services (基础眼科, insurance-reimbursable treatments covering cataract, glaucoma, strabismus, fundus diseases, ocular surface, orbital, and pediatric conditions). The company manages 31 hospitals across 7 provinces in China and 29 optometry centers, supported by specialized academic groups covering refractive surgery, cataract, glaucoma, fundus diseases, myopia prevention, and ocular surface conditions. Their service portfolio centers on comprehensive eye care from refractive correction to complex surgical procedures, supplemented by mobile eye surgery vehicles serving remote communities and international outreach to Mongolia.

Differentiator

Problem solved

Functional benefit

Brands

• 朝聚眼科·老视矫正中心: Specialized center for presbyopia correction located at Inner Mongolia Chaoju Eye Hospital, offering refractive reconstruction and personalized visual rejuvenation services.
• 包头医学院朝聚眼视光学院
• 复明24号手术车

Products and services

• Consumer Ophthalmology Services (消费眼科服务) Self-pay ophthalmology treatments not covered by public insurance, including refractive correction (LASIK, SMILE), presbyopia treatment, dry eye treatment, ocular plastic surgery, and optometry products, delivered across the group's 31 hospitals and 29 optometry centers.
• Basic Ophthalmology Services (基础眼科服务) Ophthalmology treatments partially covered by Chinese public medical insurance, including cataract, glaucoma, strabismus, fundus disease, ocular surface disease, orbital disease, and pediatric eye disease treatment delivered across the group's hospital network.
• Refractive Error Correction Surgery Comprehensive myopia, hyperopia, and astigmatism correction through SMILE, SMILE pro, LASIK, and ICL lens implantation surgical procedures performed by the Refractive Surgery Specialty Group across the group's hospitals.
• Cataract Surgery Cataract surgery using femtosecond laser-assisted technology and full-range functional intraocular lenses (multifocal, toric, extended range-of-vision) performed by the 100+ surgeon Cataract Specialty Group, leading the industry into bladeless, minimally invasive personalized customization.
• Presbyopia Correction Presbyopia treatment through refractive reconstruction and precise personalized customization delivered at dedicated Presbyopia Correction Centers, including the first Chao Ju Presbyopia Correction Center launched in Hohhot.
• Myopia Prevention and Pediatric Eye Disease Services Myopia control programs for children and adolescents including orthokeratology lens fitting, peripheral defocus glasses, low-dose atropine treatment, amblyopia training, visual function training, visual cognition training, low vision rehabilitation, and TCM ophthalmology treatment delivered by 200+ optometrists and eye doctors.
• Glaucoma Diagnosis and Treatment Glaucoma diagnosis and treatment including UCP (ultrasound ciliaryplasty), G6 micro-invasive procedures, I-TRACK canal guidance surgery, intraoperative gonioscopy-assisted goniotomy, endoscopic cyclophotocoagulation, and Xen gel stent implantation.
• Fundus Disease Treatment Vitreoretinal disease treatment including complex retinal detachment surgery, diabetic retinopathy, macular disease, vitrectomy procedures, and hereditary ocular disease and ocular trauma care delivered by the Fundus Disease Specialty Group.
• Dry Eye Diagnosis and Treatment Dry eye disease diagnosis and treatment using LipiFlow thermal pulsation, intense pulsed light (M22), and comprehensive ocular surface management delivered by the Ocular Surface Specialty Group.
• Ophthalmic Plastic Surgery Orbital and ocular plastic surgery including thyroid-related orbital disease treatment, orbital tumor removal, orbital fracture repair, endoscopic sinus surgery for oculonasal conditions, eyelid and ocular oncology surgery with rapid frozen pathology guidance, CFS ptosis surgery, double eyelid surgery, and eye bag removal.
• Optometry Center Services Vision testing, prescription glasses, contact lenses, and orthokeratology lens fitting provided through 29 dedicated optometry centers co-located with the hospital network, including AI digital customization orthokeratology lenses with anti-geometry design.
• Mobile Eye Surgery Vehicles Mobile hospital services providing free cataract surgeries in remote, grassland, and border areas. Includes the Fuming 24 mobile eye surgery vehicle which ranked first nationally for cataract surgery volume in China and operates cross-border into Mongolia as part of the Belt and Road Eye Care initiative.

Quantifiable outcome

• Over 80,000 cataract patients restored sight through charity mobile surgery vehicles
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature4 records

Partnerships

13 partnerships are on record, tiered core, strategic and minor.

• 亚洲防盲基金会 (Asia Pacific Blindness Prevention Foundation)coreStrategic or Co-development PartnerLong-term strategic partner for mobile eye surgery vehicle projects. Chaoju operates multiple mobile surgery vehicles performing free cataract surgeries. The foundation has recognized Chaoju with multiple Outstanding Contribution Awards. Partnership has enabled sight-restoration for over 80,000 patients domestically and extended to international programs in Mongolia.
• 内蒙古自治区红十字会 (Inner Mongolia Red Cross)coreStrategic or Co-development PartnerCo-implements the '光明行' charity program and '一带一路·光明行' Mongolia action, organizing free cataract surgeries in Inner Mongolia and cross-border eye care missions to Mongolia. Partnership is the institutional foundation for Chaoju's large-scale charity eye care operations.
• 包头医学院 (Baotou Medical College)coreStrategic or Co-development PartnerEstablished joint eye optometry college with Baotou Medical College in 2023. 眼视光医学 (5-year) and 眼视光学 (4-year) undergraduate programs approved and recruiting. Chaoju invested over 6 million RMB over 3 years to improve campus facilities. Co-developed ophthalmology talent pipeline.
• 温州医科大学 (Wenzhou Medical University)coreStrategic or Co-development PartnerTop ophthalmology university in China providing academic guidance for eye optometry program development. Partnered with Baotou Medical College and Chaoju on joint talent cultivation. Hosts training for Mongolia Belt and Road eye care training program participants.
• 内蒙古医科大学 (Inner Mongolia Medical University)coreStrategic or Co-development PartnerPartnership to upgrade eye optometry technology specialty to undergraduate program. Donates scholarships to support and reward academically outstanding students. Chaoju graduates make up over 200 employees in the group.
• 北京理工大学 (Beijing Institute of Technology)strategicTechnology or IntegrationCo-founded 'Environment and Health AI Collaborative Innovation Center'. Chaoju contributes millions of clinical data records for AI algorithm training. Partnership aims to develop regional eye health risk warning models combining AI with eye disease research.
• 用友集团 (Yonyou)strategicTechnology or IntegrationSigned strategic cooperation agreement in October 2023 for healthcare digital transformation. Deploying HOP platform for data-driven operational management, financial digitalization, and intelligent cost control to improve hospital management efficiency.
• 中国医学科学院药物研究院 (Chinese Academy of Medical Sciences Institute of Medicine)strategicStrategic or Co-development PartnerSigned self-developed drug R&D project agreement in June 2024. Aims to develop pharmaceutical treatments for adolescent myopia, filling a gap in the field. Both parties contributing R&D resources and expertise.
• 中山大学中山眼科中心 (Zhongshan University Eye Center)strategicStrategic or Co-development Partner'百城光明行' (100-City Bright Vision Tour) partnership. Deploys 5G smart mobile eye screening vehicles to Inner Mongolia. Combines screening, diagnosis, and treatment. Provides free cataract surgeries at Chaoju hospitals. Promotes multi-disciplinary exchanges, new technology introduction, and talent cultivation.
• 蔡司 (ZEISS)coreTechnology or IntegrationCore technology equipment partner providing VisuMax femtosecond laser, LENSAR laser cataract systems, ARTEVO 800 3D digital navigation microscope, and SMILE pro technology. Chaoju was among the first in China to deploy SMILE 4.0 technology. Partnership also includes talent training programs and academic exchange.
• 余彭年慈善基金会 (Yu Pengnian Charity Foundation)minorStrategic or Co-development Partner彭年光明行动 charity program where foundation provides funding, with Chaoju hospitals providing surgical execution for 830 free cataract surgeries for low-income patients in Zhangjiakou.
• 中山大学中山眼科中心 (Zhongshan University Eye Center)strategicStrategic or Co-development PartnerHosted '百年校庆·百城光明行' Inner Mongolia station with 5G smart mobile eye screening vehicles. Screened 248 residents in Hohhot and provided free cataract surgeries at Chaoju hospitals. Partnership facilitates technology exchange and new program introduction.
• 蒙古国红十字会 (Mongolia Red Cross)coreStrategic or Co-development PartnerBilateral eye care partnership under Belt and Road initiative. Annual free cataract surgeries for Mongolian patients at Erenhot border city. Mongolian Red Cross organizes patient transportation and logistics. Partnership has performed over 600 surgeries for Mongolian patients.

Scale indicators10 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Aier Eye Hospital Group: China's largest private ophthalmology chain (300015.SZ), operating 800+ centers globally. Directly competes with Chaoju across cataract, refractive, optometry, and pediatric services, with materially larger scale and broader geographic reach.
• PRNJ Bright Eye Group: Shenzhen ChiNext-listed ophthalmology chain (301267.SZ) operating ~30 hospitals across China. Closest direct peer in scale, multi-subspecialty model, and listed-equity comparability.
• C-MER Dennis Lam Eye Hospital Group: Hong Kong-listed ophthalmology group (3309.HK) founded by Dr. Dennis Lam. Comparable HKEX-listed specialty ophthalmology chain with cross-border (Mainland China + HK) expansion model.
• Huaxia Eye Hospital Group: Large private Chinese ophthalmology hospital group with multi-province footprint. Closely comparable to Chaoju in operating model—multi-site specialty hospitals covering cataract, refractive, and optometry services.

Broad incumbents

• Topchoice Medical: Shanghai-listed (600763.SH) private specialty hospital group primarily in dental but with adjacent specialty-hospital playbook. Comparable as a listed multi-site specialty healthcare operator with similar capital-markets profile.

Regional players

• Phoenix Healthcare Group: Hong Kong-listed (1515.HK) integrated healthcare services group operating hospitals and clinic networks in Mainland China. Comparable as a HKEX-listed multi-site healthcare operator, though broader than pure ophthalmology.

Others

• Carl Zeiss Meditec: German ophthalmic equipment manufacturer (VisuMax, LENSAR, ARTEVO 800) and Chaoju's core technology partner. Adjacent enabler rather than competitor; provides the equipment backbone Chaoju's premium refractive/cataract offering depends on.
• Alcon: Global ophthalmic devices and consumer eye-care company. Former employer of Chaoju's COO; supplier of IOLs and surgical equipment. Enabling ecosystem participant rather than direct competitor.
• STAAR Surgical: US-listed manufacturer of ICL (Implantable Collamer Lens) used in Chaoju's refractive surgery offerings. Technology supplier whose products underpin Chaoju's premium consumer refractive service line.
• Bausch + Lomb: Global ophthalmic pharmaceutical and device company, including IOLs and contact lens portfolio. Competes with Alcon/STAAR as a supplier of ophthalmic consumables that Chaoju's hospitals procure.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries19 records

Funding overview

Funding rounds3 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Chao Ju Ophthalmology